About Dr. Martin Goodman
Dr. Martin Goodman has been in practice for more than 20 years and is currently a highly sought-after board-certified surgeon at Tufts Medical Center in Boston, Massachusetts.
Dr. Goodman is noted as one of the pioneers of the HIPEC procedure, which is a form of heated chemotherapy applied directly to the abdominal cavity. It is designed to treat tumors in patients with peritoneal mesothelioma. In the past, many patients with the disease were considered terminally ill, but thanks to medical professionals such as Dr. Goodman, patients are living longer, better lives as a result of the procedure.
Tufts Medical Center was the first hospital in Massachusetts to use the HIPEC procedure to treat conditions such as peritoneal mesothelioma, giving new hope to patients in the state.
Dr. Goodman is now the director of the Peritoneal Surface Malignancy Program. He’s also an assistant professor of surgery at the Tufts University School of Medicine.
Dr. Goodman’s Location
Dr. Goodman works at Tufts Medical Center in Boston, Massachusetts. He is one of 28 doctors in the center who specialize in surgery.
Tufts Medical Center
South Building, 4th Floor
800 Washington St.
Boston, MA 02111
Dr. Goodman’s Career Highlights
Dr. Goodman is well-known for treating his patients with cytoreduction surgery and HIPEC (hyperthermic intraperitoneal chemotherapy), but his other achievements include:
- Becoming a Fellow of the American College of Surgeons
- Being recruited by Tufts Medical Center as Director of the Advanced Abdominal Tumor and Peritoneal Surface Malignancy Program
- Publishing his book ‘Regional Therapeutics for Advanced Malignancies’—a guide to treating cancer in various parts of the body
Dr. Goodman’s Background
Dr. Goodman studied medicine at Rutgers Robert Wood Johnson Medical School, New Jersey, and received his medical degree in 1994. He undertook an internship at New York Medical College before going on to complete his residency at Cooper University Hospital and a surgical oncology fellowship at the University of Pittsburgh.
Dr. Goodman then took a position as Director of Surgical Oncology at Dorothy Schneider Cancer Center in California, opening the first and only Peritoneal Surface Malignancy Program in Northern California.
After devoting the majority of his career to finding the cure to some of the rarest and difficult cancers—including peritoneal mesothelioma—Tufts Medical Center recruited Dr. Goodman and he became Director of their Advanced Abdominal Tumor and Peritoneal Surface Malignancy Program in July 2007.
Dr. Goodman is also a Fellow of the American College of Surgeons and a member of:
- Society for Surgical Oncology
- American Society of Clinical Oncology
- Society for Surgery of the Alimentary Tract
Dr. Goodman specializes in hyperthermic intraperitoneal chemotherapy (HIPEC) treatment, which has been shown to improve the overall survival of peritoneal mesothelioma patients. This treatment is revolutionary for peritoneal mesothelioma patients and is typically performed in conjunction with cytoreductive surgery.
Cytoreduction is a procedure that can take 8-12 hours to complete. The surgeon begins by opening the abdomen, examining the organs and removing any tumors. In extreme cases, some affected organs may also be removed.
Hyperthermic Intraperitoneal Chemotherapy (HIPEC)
After the cytoreductive surgery, the abdomen will be partially closed before a heated chemotherapy solution is applied directly to the cavity.
The HIPEC solution is heated to 109 degrees Fahrenheit as cancer cells die at around 104 degrees and healthy cells at 111 degrees. This median temperature kills the cancerous cells while not damaging the healthy cells.
The abdomen will then be closed for between 60-90 minutes to allow the chemotherapy to treat the remaining tumors and remove mesothelioma cells. The solution is then removed and sometimes followed by radiation before the abdomen is closed for a final time.
Annually, Dr. Goodman and his specialized team perform around 40-50 HIPEC procedures. The treatment is known to improve and prolong mesothelioma patients’ lives.
Speaking for Tufts Medical Center, Dr. Goodman says:
“Doing this procedure can definitely prologue the time intervals when the tumor might recur, and [the patient] won’t have to be on chemotherapy for the rest of their lives. In some cases, potentially, you can cure patients, whereas before it was incurable.”
Dr. Goodman’s Career Accomplishments
Dr. Goodman has saved the lives of hundreds of patients during his career. As the director of the Peritoneal Surface Malignancy Program and an assistant professor of surgery at the Tufts University School of Medicine, he has devoted his life to research and surgery in the hope of finding a cure for peritoneal cancers.
Awards & Honors
- Top Doctors for Cancer, Castle Connolly, 2017
- Resident Teaching Award, Tufts MC, 2017
- Voted “Top Doctor’ by Boston Magazine in 2017, 2015, 2013, 2012, 2011 & 2010
- 2015, “Top Cancer Doctors 2015,” Newsweek
- Schwartz Center Compassionate Caregiver Award
- Fellow of the American College of Surgeons
Dr. Goodman’s Current Work
As director of the Peritoneal Surface Malignancy Program at Tufts, Dr. Goodman is a world leader in the treatment of peritoneal mesothelioma. He is trained in every aspect of the HIPEC procedure and is adept at knowing how to handle each patient to maximize their recovery.
“Our results—when you look at the data across the country as well as internationally—are excellent. I’ve probably done 250 of these in my career, so we know what problems to potentially expect and how to take care of them. That’s really where the experience comes into play.” — Dr. Goodman.
Notable Work by Dr. Goodman
Dr. David Goodman is renowned for his book ‘Regional Therapeutics for Advanced Malignancies’, a short guide to the treatment of cancer around the body, including peritoneal diseases. It’s the most comprehensive guide available regarding therapeutic technologies for treating rare and advanced cancers by their disease locations.
Dr. Goodman’s book ‘Regional Therapeutics for Advanced Malignancies’ is taught in medical schools, helping the next generation of specialized oncologists understand rare and aggressive cancers. It’s also widely recognized as a handbook and guide for existing medical professionals to help improve patient treatment.
Dr. Goodman’s Healing Philosophy
Dr. Goodman’s goal is to give each of his patients the chance to live a longer, pain-free life. He believes that the HIPEC procedure can do this—especially in comparison to other peritoneal mesothelioma treatments.
In contrast to patients who receive regular chemotherapy, patients who undergo the HIPEC procedure (with direct, heated chemotherapy) have been shown to live longer. However, while the surgery can take up to 12 hours, the recovery afterward will take many months. Only patients who are strong enough to survive the recovery will be eligible for the HIPEC treatment, as the feeling of exhaustion is extremely common.
“It’s going to take 2-3 months to feel almost back to normal. [The patient] will be very fatigued and exhausted during that time period, but I tell them to get up and move around… every day do a little bit more.” —Dr. Goodman.
Dr. Goodman says that patients need to prepare themselves for the feeling of fatigue throughout their extensive recovery. Bleeding and infections are two of the most common issues that can happen after the procedure, and while the risk of complications is higher than with other operations, as are the results.